Psychedelics show promise where few other drugs have
and reducing inflammation throughout the body. The research funding earmarked in the bill could help suss out whether those hypotheses are right.
That’s been the case for Renée, 53, who also asked to be identified by only her first name. After a suspected case of COVID-19 in 2020 left her with smell loss, a rapid heart rate, dizziness, ringing in her ears, brain fog, psychosis, hallucinations, and, she decided to try microdosing: taking just enough of a psychedelic to spark a physiological effect, but not enough to get high. She started by taking small amounts of LSD every few days for a month.
While some people, like Renée, regularly use small doses of psychedelics, Dr. Saleena Subaiya, a physician and researcher at Columbia University Irving Medical Center who also has Long COVID, is launching a small pilot trial to explore whether single-dose hallucinogenic treatments can relieve Long COVID symptoms.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Kyle Kirkwood goes from promising to proven with Grand Prix of Long Beach winWith Bryan Herta in his corner providing guidance, Kyle Kirkwood earns his first IndyCar Series win in a dominant showing at the Grand Prix of Long Beach.
Read more »
Virgin Orbit was a promising company that could never find a working business modelVirgin Orbit targeted the small satellite launch market, catering to customers whose satellites weighed up to 500 kilograms or 1,100 pounds.
Read more »
CBRE’s promising Manhattan retail report overlooks vacant midtown Sixth AveThings look rosier for Manhattan’s retail market than they have for a while — if you believe the stats, that is.
Read more »
Promising senior, 4 others slain in Alabama party shootingA high school senior who planned to play college football was celebrating at his sister’s 16th birthday party Saturday night in Alabama when gunfire killed him and three other people and wounded several others
Read more »
Moderna shares fall despite promising data from cancer vaccine trialModerna's mRNA vaccine, when combined with Merck's blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer.
Read more »